ABO Blood Group as a Prognostic Factor in Patients with Diffuse Large B Cell Lymphoma

Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):561-562. doi: 10.1016/j.clml.2020.03.001. Epub 2020 Mar 16.

Authors

Parastou Tizro¹, Min Ling Liu², Anita Aggarwal³, Victor E Nava²

Affiliations

¹ Department of Pathology, George Washington University, Washington, DC. Electronic address: ptizro@gwu.edu.
² Department of Pathology, George Washington University, Washington, DC; Department of Pathology, Veterans Health Administration, Washington, DC.
³ Department of Hematology and Oncology, Veterans Health Administration, Washington, DC.

PMID: 32360275
DOI: 10.1016/j.clml.2020.03.001

No abstract available

Publication types

Letter
Comment

MeSH terms

Blood Group Antigens*
Humans
Lymphoma, Large B-Cell, Diffuse* / diagnosis
Lymphoma, Large B-Cell, Diffuse* / drug therapy
Prognosis

Substances

Blood Group Antigens